CRISPR Therapeutics (CRSP) PT Raised to $75 at Goldman Sachs

November 19, 2019 1:00 PM

Goldman Sachs analyst Salveen Richter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found